» Articles » PMID: 39680378

Characterization of the Ocular Phenotype in a Col4a3 Knockout Mouse Model of Alport Syndrome

Overview
Specialty Ophthalmology
Date 2024 Dec 16
PMID 39680378
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Alport syndrome (AS) is a genetic condition caused by a dysfunctional collagen (IV) α3α4α5 heterotrimer, leading to basement membrane instability and, ultimately, abnormalities in the kidney, inner ear, and eyes. This study aimed to characterize ocular pathology of AS by focusing on inflammatory and fibrotic markers.

Methods: Col4a3tm1Dec knockout (KO) mice eyes were evaluated for the localization of collagen (IV) α3 and collagen (IV) α4, then stained for transforming growth factor-β1 (TGF-β1), TGF-β2, connective tissue growth factor (CTGF), and β-catenin. mRNA levels of the profibrotic genes S100a4, Acta2, Col1a1, Snai1, Snai2, and Twist1 were assessed using real-time reverse transcription quantitative PCR (RT-qPCR).

Results: Collagen (IV) α3 and collagen (IV) α4 were co-expressed in Descemet's and Bruch's membrane but not in the retina, lens, or other corneal substructures. Immunofluorescence quantitation revealed upregulation of TGF-β1 in the anterior lens and TGF-β2 in the retina of KO eyes. Conversely, CTGF and β-catenin were shown to be elevated in the corneal epithelium but not the retina or lens. RT-qPCR showed an increase in the transcription of Acta2, Col1a1, and Snai2 in the retinas and Snai2 in anterior segments of KO mice.

Conclusions: Col4a3 KO mice exhibited a differential inflammatory and profibrotic response in the cornea, retina, and lens, which may play a role in the ocular pathology of AS.

References
1.
Jones B, Myakala K, Guha M, Davidson S, Adapa S, Lopez Santiago I . Farnesoid X receptor prevents neutrophil extracellular traps via reduced sphingosine-1-phosphate in chronic kidney disease. Am J Physiol Renal Physiol. 2023; 325(6):F792-F810. PMC: 10894665. DOI: 10.1152/ajprenal.00292.2023. View

2.
Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T . A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2018; 23(2):158-168. PMC: 6510800. DOI: 10.1007/s10157-018-1629-4. View

3.
Grotendorst G . Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 1998; 8(3):171-9. DOI: 10.1016/s1359-6101(97)00010-5. View

4.
Kalluri R, Shield C, Todd P, Hudson B, Neilson E . Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest. 1997; 99(10):2470-8. PMC: 508088. DOI: 10.1172/JCI119431. View

5.
Rhys C, Snyers B, Pirson Y . Recurrent corneal erosion associated with Alport's syndrome. Rapid communication. Kidney Int. 1997; 52(1):208-11. DOI: 10.1038/ki.1997.321. View